Find all
associated with


Refine your query (more in Advanced-Search):
 Focus on the recent 5 years   Focus on the current year   Focus on the last 30 days   More choices ...
 Focus on articles with free fulltexts   More choices ...
 Do simple 'keyword' search (no query expansion)

[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 10 of about 73247
1. Xu M, Guo Q, Wang S, Wang N, Wei L, Wang J: Anti-rheumatoid arthritic effects of Saussurea involucrata on type II collagen-induced arthritis in rats. Food Funct; 2016 Feb;7(2):763-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anti-rheumatoid arthritic effects of Saussurea involucrata on type II collagen-induced arthritis in rats.
  • Saussurea involucrata (SI) has long been used under the herbal name "snow lotus" for treatment of inflammation and pain-related diseases in traditional Chinese medicine.
  • The present study aimed to evaluate the pharmacological effects of SI on collagen II (CII)-induced arthritis in rats.
  • Rats with collagen II (CII)-induced arthritis were orally administered SI (420 mg kg(-1)) for 40 consecutive days.
  • Histopathological examination indicated that SI alleviates infiltration of inflammatory cells and synovial hyperplasia and slows joint destruction.
  • Results also showed that SI is a potential therapeutic agent for alleviating the severity of the disease based on the reduced arthritic index.
  • It was concluded that SI can ameliorate inflammation and joint destruction in CIA rats.
  • [MeSH-major] Antirheumatic Agents / administration & dosage. Arthritis, Rheumatoid / drug therapy. Collagen Type II / adverse effects. Drugs, Chinese Herbal / administration & dosage. Saussurea / chemistry
  • [MeSH-minor] Animals. Arthritis, Experimental. C-Reactive Protein / immunology. Disease Models, Animal. Humans. Male. Rats. Rats, Sprague-Dawley

  • Genetic Alliance. consumer health - Arthritis.
  • Genetic Alliance. consumer health - Rheumatoid arthritis.
  • MedlinePlus Health Information. consumer health - Rheumatoid Arthritis.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 26508519.001).
  • [ISSN] 2042-650X
  • [Journal-full-title] Food & function
  • [ISO-abbreviation] Food Funct
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antirheumatic Agents; 0 / Collagen Type II; 0 / Drugs, Chinese Herbal; 9007-41-4 / C-Reactive Protein
  •  go-up   go-down


2. Tao X, Sun Y, Zhang N: [Treatment of rheumatoid arthritis with low doses of multi-glycosides of Tripterygium wilfordii]. Zhong Xi Yi Jie He Za Zhi; 1990 May;10(5):289-91, 261-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Treatment of rheumatoid arthritis with low doses of multi-glycosides of Tripterygium wilfordii].
  • Thirty two cases of rheumatoid arthritis were treated with multi-glycosides of Tripterygium wilfordii (T2) in a dosage of 30 mg daily for 12 weeks.
  • It is suggested that it is reasonable to choose the dose of 30 mg daily as the routine treatment for rheumatoid arthritis patients.

  • Genetic Alliance. consumer health - Arthritis.
  • Genetic Alliance. consumer health - Rheumatoid arthritis.
  • MedlinePlus Health Information. consumer health - Rheumatoid Arthritis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 2397546.001).
  • [ISSN] 0254-9034
  • [Journal-full-title] Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine
  • [ISO-abbreviation] Zhong Xi Yi Jie He Za Zhi
  • [Language] CHI
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Drugs, Chinese Herbal
  •  go-up   go-down


3. Jakobsson U, Hallberg IR: Pain and quality of life among older people with rheumatoid arthritis and/or osteoarthritis: a literature review. J Clin Nurs; 2002 Jul;11(4):430-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pain and quality of life among older people with rheumatoid arthritis and/or osteoarthritis: a literature review.
  • The aim of this study was to review the research literature on pain and quality of life (QoL) and the relationship between these variables among people aged 75 years and above with rheumatoid arthritis and/or osteoarthritis.
  • A Medline and CINAHL search was carried out using MeSH terms rheumatoid arthritis, osteoarthritis, QoL and pain in various combinations.
  • Pain was common in both groups and was found to increase with age and disease duration among those with rheumatoid arthritis but not among those with osteoarthritis.
  • Pain, functional limitation and increased age were found to decrease QoL among those with rheumatoid arthritis and osteoarthritis alike.
  • Social support was found to buffer against negative effects on QoL among those with osteoarthritis while no moderating effects were found in rheumatoid arthritis.
  • Increased age was found to relate to pain (rheumatoid arthritis) and decrease QoL (both rheumatoid arthritis and osteoarthritis).
  • Thus, research about pain and QoL, especially focusing on the old and the very elderly with rheumatoid arthritis/osteoarthritis, is needed.
  • It also seems justified to say that nursing care should especially focus on older people and that these people should be assessed for their level of pain, functional limitations and QoL especially in the case of having rheumatoid arthritis and/or osteoarthritis.
  • [MeSH-major] Arthritis, Rheumatoid / complications. Osteoarthritis / complications. Pain / etiology. Quality of Life


Advertisement
4. Cheung C, Geisler C, Sunneberg J: Complementary/alternative medicine use for arthritis by older women of urban-rural settings. J Am Assoc Nurse Pract; 2014 May;26(5):273-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Complementary/alternative medicine use for arthritis by older women of urban-rural settings.
  • PURPOSE: This study described the use of complementary/alternative medicine (CAM) for arthritis management among community-dwelling older women in urban, suburban, and rural areas.
  • A purposive sample of 50 women ages 66-101 who managed arthritis with CAM participated in eight semistructured focus groups: rural (n=22), suburban (n=17), and urban areas (n=11).
  • IMPLICATIONS FOR PRACTICE: Results suggest a strong need for primary HCP to purposely dialogue with their clients on CAM use when designing, organizing, and delivering arthritis care.
  • Information on safe CAM use and greater options for effective arthritis management with CAM are needed.
  • The value of group-based model for treating arthritis deserves further exploration.
  • [MeSH-major] Arthritis / drug therapy. Complementary Therapies / utilization. Rural Population. Urban Population


5. Sbiti M, Bouhamidi B, Louzi L: [Proteus mirabilis septic arthritis]. Pan Afr Med J; 2017;26:197
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Proteus mirabilis septic arthritis].
  • [Transliterated title] Arthrite septique à Proteus mirabilis.
  • Acute septic arthritis is rare.
  • We report the case of a 61-year old patient with spontaneous Proteus mirabilis septic arthritis.
  • Patient's evolution was favorable thanks to early diagnosis and initiation of adequate antibiotic therapy.
  • Proteus mirabilis septic arthritis is rare.
  • On that basis we conducted a literature review of cases of Proteus mirabilis pyogenic arthritis to highlight the risk factors, pathogenesis, treatment and evolution of these diseases.
  • Diagnosis is commonly based on microbiological analysis, early articular puncture biopsy is performed before the initiation of antibiotic treatment, direct examination, culture and antibiogram which are useful as guidance for antibiotic therapy.
  • Septic arthritis is a diagnostic and therapeutic emergency; early management of this disease allows total healing without after-effects.
  • [MeSH-major] Anti-Bacterial Agents / therapeutic use. Arthritis, Infectious / diagnosis. Proteus Infections / diagnosis. Proteus mirabilis / isolation & purification
  • [MeSH-minor] Acute Disease. Humans. Male. Middle Aged. Prognosis. Risk Factors. Synovial Fluid / microbiology

  • Genetic Alliance. consumer health - Arthritis.
  • MedlinePlus Health Information. consumer health - Antibiotics.
  • MedlinePlus Health Information. consumer health - Infectious Arthritis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Afr J Med Med Sci. 1996 Mar;25(1):7-12 [9110049.001]
  • [Cites] Rev Rhum Engl Ed. 1996 Feb;63(2):103-10 [8689280.001]
  • [Cites] Arthritis Rheum. 1995 Dec;38(12):1819-25 [8849354.001]
  • [Cites] Pediatr Radiol. 1984;14 (5):318-22 [6472917.001]
  • [Cites] Arthritis Rheum. 1980 Aug;23(8):889-97 [6773530.001]
  • [Cites] Handchir Mikrochir Plast Chir. 2007 Apr;39(2):112-7 [17497607.001]
  • [Cites] J Med Assoc Thai. 1990 Nov;73(11):615-23 [2283490.001]
  • [Cites] Clin Microbiol Infect. 2006 Apr;12(4):309-14 [16524406.001]
  • [Cites] Ann Rheum Dis. 1986 Jun;45(6):458-63 [3729573.001]
  • [Cites] Ann Thorac Surg. 2002 Feb;73(2):427-31 [11845854.001]
  • [Cites] Rev Chir Orthop Reparatrice Appar Mot. 2006 Dec;92(8 Suppl):4S46-54 [17245253.001]
  • [Cites] Clin Med (Lond). 2005 Jul-Aug;5(4):420-1 [16138503.001]
  • [Cites] Clin Microbiol Rev. 2002 Oct;15(4):527-44 [12364368.001]
  • [Cites] Isr Med Assoc J. 2001 Jan;3(1):75-6 [11344817.001]
  • [Cites] Ann Rheum Dis. 1999 Apr;58(4):214-9 [10364899.001]
  • [Cites] South Med J. 1990 May;83(5):589-91 [2188375.001]
  • [Cites] Best Pract Res Clin Rheumatol. 2011 Jun;25(3):407-21 [22100289.001]
  • [Cites] Ann Rheum Dis. 1986 Jun;45(6):454-7 [3524479.001]
  • [Cites] Rev Infect Dis. 1985 Nov-Dec;7 Suppl 4:S783-8 [2934786.001]
  • (PMID = 28674590.001).
  • [ISSN] 1937-8688
  • [Journal-full-title] The Pan African medical journal
  • [ISO-abbreviation] Pan Afr Med J
  • [Language] fre
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Uganda
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents
  • [Keywords] NOTNLM ; Proteus mirabilis / Septic arthritis / risk factors
  •  go-up   go-down


6. Chen Z, Li RL, Tu SH: [The investigation and progress of the cellular and molecular biological mechanisms of Tripterygium wilfordii in treating rheumatoid arthritis]. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Feb;29(2):183-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The investigation and progress of the cellular and molecular biological mechanisms of Tripterygium wilfordii in treating rheumatoid arthritis].

  • Genetic Alliance. consumer health - Arthritis.
  • Genetic Alliance. consumer health - Rheumatoid arthritis.
  • MedlinePlus Health Information. consumer health - Herbal Medicine.
  • MedlinePlus Health Information. consumer health - Rheumatoid Arthritis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19382484.001).
  • [ISSN] 1003-5370
  • [Journal-full-title] Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine
  • [ISO-abbreviation] Zhongguo Zhong Xi Yi Jie He Za Zhi
  • [Language] CHI
  • [Publication-type] Journal Article; Review
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents, Non-Steroidal; 0 / Cytokines; 0 / Drugs, Chinese Herbal; 0 / Immunosuppressive Agents
  • [Number-of-references] 26
  •  go-up   go-down


7. Takahashi Y, Tanaka M, Murai R, Kuribayashi K, Kobayashi D, Yanagihara N, Watanabe N: Prophylactic and therapeutic effects of Acanthopanax senticosus Harms extract on murine collagen-induced arthritis. Phytother Res; 2014 Oct;28(10):1513-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prophylactic and therapeutic effects of Acanthopanax senticosus Harms extract on murine collagen-induced arthritis.
  • In this study, we examined prophylactic and therapeutic effects of ASH extract (ASHE) on rheumatoid arthritis using collagen-induced arthritis (CIA) mouse model.
  • Acanthopanax senticosus Harms extract was administered before the onset of arthritis in the prophylaxis model.
  • In the therapeutic model, ASHE was administered after the onset of arthritis with or without anti-TNF-α antibody.
  • The combination therapy with ASHE and anti-TNF-α antibody reduced the severity of arthritis compared with anti-TNF-α antibody alone.
  • [MeSH-major] Arthritis, Experimental / drug therapy. Eleutherococcus / chemistry. Leukocytes, Mononuclear / drug effects. Plant Extracts / pharmacology
  • [MeSH-minor] Animals. Anti-Inflammatory Agents / pharmacology. Antirheumatic Agents / pharmacology. Arthritis, Rheumatoid. Disease Models, Animal. Humans. Interleukin-6 / metabolism. Male. Mice. Mice, Inbred DBA. Tumor Necrosis Factor-alpha / metabolism

  • Genetic Alliance. consumer health - Arthritis.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2014 The Authors. Phytotherapy Research published by John Wiley & Sons Ltd.
  • [Cites] Autoimmun Rev. 2007 Nov;7(1):65-70 [17967728.001]
  • [Cites] Nat Rev Immunol. 2007 Jun;7(6):429-42 [17525752.001]
  • [Cites] Int J Environ Res Public Health. 2009 Feb;6(2):445-62 [19440393.001]
  • [Cites] Ann Rheum Dis. 2010 Jun;69(6):976-86 [20447957.001]
  • [Cites] Pharmazie. 2011 Feb;66(2):83-97 [21434569.001]
  • [Cites] Phytother Res. 2011 Jun;25(6):940-3 [21626600.001]
  • [Cites] J Biol Chem. 2012 Dec 7;287(50):42269-77 [23066015.001]
  • [Cites] Arthritis Rheum. 2000 Feb;43(2):320-8 [10693871.001]
  • [Cites] Free Radic Res. 2000 Jun;32(6):479-86 [10798713.001]
  • [Cites] J Ethnopharmacol. 2000 Oct;72(3):345-93 [10996277.001]
  • [Cites] Clin Chim Acta. 2001 Oct;312(1-2):163-8 [11580922.001]
  • [Cites] Arthritis Rheum. 2001 Sep;44(9):2160-7 [11592381.001]
  • [Cites] Arthritis Rheum. 2002 Feb;46(2):522-32 [11840456.001]
  • [Cites] J Ethnopharmacol. 2002 Mar;79(3):347-52 [11849840.001]
  • [Cites] Am J Nephrol. 2002 Jan-Feb;22(1):6-10 [11919396.001]
  • [Cites] Free Radic Biol Med. 2002 Nov 1;33(9):1231-42 [12398931.001]
  • [Cites] Phytother Res. 2003 Apr;17(4):353-7 [12722139.001]
  • [Cites] Arthritis Res Ther. 2003;5(5):R234-40 [12932286.001]
  • [Cites] Nature. 1980 Feb 14;283(5748):666-8 [6153460.001]
  • [Cites] Chem Pharm Bull (Tokyo). 1990 Jun;38(6):1763-5 [2208394.001]
  • [Cites] Biochem J. 1991 Jan 15;273(Pt 2):459-67 [1991041.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9784-8 [1409699.001]
  • [Cites] J Rheumatol. 1993 Nov;20(11):1830-5 [8308766.001]
  • [Cites] Blood. 1995 Aug 15;86(4):1243-54 [7632928.001]
  • [Cites] J Immunol. 1995 Nov 15;155(10):4948-54 [7594500.001]
  • [Cites] Cell. 1996 May 3;85(3):307-10 [8616886.001]
  • [Cites] Arthritis Rheum. 1996 May;39(5):732-5 [8639169.001]
  • [Cites] Med Sci Sports Exerc. 1996 Apr;28(4):482-9 [8778554.001]
  • [Cites] Biol Pharm Bull. 1996 Sep;19(9):1227-30 [8889047.001]
  • [Cites] J Am Soc Nephrol. 1997 Sep;8(9):1405-14 [9294832.001]
  • [Cites] Arthritis Res Ther. 2004;6(6):265-78 [15535839.001]
  • [Cites] Arthritis Rheum. 2004 Nov;50(11):3702-11 [15529385.001]
  • [Cites] Immunology. 2005 May;115(1):1-20 [15819693.001]
  • [Cites] Int J Biochem Cell Biol. 2007;39(1):44-84 [16978905.001]
  • [Cites] Phytother Res. 2008 Jun;22(6):740-5 [18446849.001]
  • (PMID = 24797499.001).
  • [ISSN] 1099-1573
  • [Journal-full-title] Phytotherapy research : PTR
  • [ISO-abbreviation] Phytother Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents; 0 / Antirheumatic Agents; 0 / IL6 protein, human; 0 / Interleukin-6; 0 / Plant Extracts; 0 / Tumor Necrosis Factor-alpha
  • [Other-IDs] NLM/ PMC4235467
  • [Keywords] NOTNLM ; Acanthopanax senticosus Harms / anti-TNF-α antibody / collagen-induced arthritis / inflammatory cytokines / reactive oxygen species
  •  go-up   go-down


8. Incorrect panel of figure in the article by Margheri et al (Arthritis Rheum, August 2010). Arthritis Rheumatol; 2015 May;67(8):2175
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incorrect panel of figure in the article by Margheri et al (Arthritis Rheum, August 2010).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumFor] Arthritis Rheum. 2010 Aug;62(8):2488-98 [20506099.001]
  • (PMID = 26226239.001).
  • [ISSN] 2326-5205
  • [Journal-full-title] Arthritis & rheumatology (Hoboken, N.J.)
  • [Language] eng
  • [Publication-type] Published Erratum
  • [Publication-country] United States
  •  go-up   go-down


9. Messier SP, Loeser RF, Miller GD, Morgan TM, Rejeski WJ, Sevick MA, Ettinger WH Jr, Pahor M, Williamson JD: Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial. Arthritis Rheum; 2004 May;50(5):1501-10
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial.
  • OBJECTIVE: The Arthritis, Diet, and Activity Promotion Trial (ADAPT) was a randomized, single-blind clinical trial lasting 18 months that was designed to determine whether long-term exercise and dietary weight loss are more effective, either separately or in combination, than usual care in improving physical function, pain, and mobility in older overweight and obese adults with knee osteoarthritis (OA).
  • Secondary outcomes included weight loss, 6-minute walk distance, stair-climb time, WOMAC pain and stiffness scores, and joint space width.
  • Finally, changes in joint space width were not different between the groups.


10. Xu X, Li QJ, Xia S, Wang MM, Ji W: Tripterygium Glycosides for Treating Late-onset Rheumatoid Arthritis: A Systematic Review and Meta-analysis. Altern Ther Health Med; 2016 Nov;22(6):32-39
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tripterygium Glycosides for Treating Late-onset Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
  • Context • Older- or late-onset rheumatoid arthritis (LORA) is defined as rheumatoid arthritis (RA) with an onset of symptoms at age 60 y or older, which includes a specific clinical course and features.
  • The research team included randomized, controlled trials (RCTs) in which Tripterygium glycosides were employed, either alone or as an adjuvant treatment with disease-modifying antirheumatic drugs (DMARDs), in patients with LORA.
  • Outcome Measures • The primary outcomes included (1) the swollen joint count (SJC) and (2) the tender joint count (TJC).
  • [MeSH-major] Arthritis, Rheumatoid / drug therapy. Plant Extracts / therapeutic use. Tripterygium






Advertisement